Generic Name and Formulations:
Racepinephrine 2.25%; inh soln.
Indications for ASTHMANEFRIN:
For temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma.
Adults and Children:
For use in an atomizer (eg, EZ Breathe Atomizer). Add contents of one vial (0.5mL) to atomizer. <4yrs: not recommended. ≥4yrs: 1–3 inhalations not more than every 3 hours.
Within 14 days of MAOIs.
Heart disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma requiring hospitalization. Discontinue and reevaluate if symptoms are not relieved within 20 minutes or worsen. Do not use if product is brown, pinkish or darker than slightly yellow in color, if it appears cloudy, or if it contains a precipitate. Pregnancy. Nursing mothers.
Caution with concomitant other asthma drugs.
Nervousness, tachycardia with excessive use.
Starter Kit—1 (10 vials + 1 EZ Breathe Atomizer); Refill vials—30
Clinical Pain Advisor Articles
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Opioid-Free Analgesia Use for Postsurgical Pain Limited
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- No Added Value With Liposomal Bupivacaine Following TKA With Peripheral Nerve Block
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Opioid-Related Deaths Represent Significant Public Health Burden
- Addressing Confidentiality Concerns With Electronic Access to Pediatric Medical Records
- Opioid-Related Adverse Events Common After Invasive Procedures
- Diagnosis and Treatment of Migraine in Children Should Consider Atopy
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit